Christophe Borg

Christophe Borg

UNVERIFIED PROFILE

Are you Christophe Borg?   Register this Author

Register author
Christophe Borg

Christophe Borg

Publications by authors named "Christophe Borg"

Are you Christophe Borg?   Register this Author

99Publications

3734Reads

38Profile Views

CD4 T cells target colorectal cancer antigens upregulated by oxaliplatin.

Int J Cancer 2019 Dec 31;145(11):3112-3125. Epub 2019 Aug 31.

Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32620DOI Listing
December 2019

[Radiologic response assessment in metastatic colorectal cancers].

Bull Cancer 2019 Sep 27. Epub 2019 Sep 27.

University Hospital, Department of Medical Oncology, 25000 Besançon, France; University of Franche-Comté, Unit 1098, Inserm, 25000 Besançon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2019.08.013DOI Listing
September 2019

Ramucirumab and paclitaxel in patients with gastric cancer and prior trastuzumab: subgroup analysis from RAINBOW study.

Future Oncol 2019 Aug 25;15(23):2723-2731. Epub 2019 Jun 25.

Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, 464-8681, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2019-0243DOI Listing
August 2019

Long-term adverse event: inflammatory orbitopathy induced by pembrolizumab in a patient with metastatic melanoma.

Invest New Drugs 2019 04 25;37(2):375-377. Epub 2018 Aug 25.

Service de Dermatologie, Centre Hospitalier Universitaire, 3 Boulevard Alexandre Fleming, 25030, Besançon cedex, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-018-0659-9
Publisher Site
http://dx.doi.org/10.1007/s10637-018-0659-9DOI Listing
April 2019

EMT is associated with an epigenetic signature of ECM remodeling genes.

Cell Death Dis 2019 Feb 27;10(3):205. Epub 2019 Feb 27.

Univ. Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41419-019-1397-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393505PMC
February 2019

Biologie, concepts et principes des CAR-T cells.

Bull Cancer 2018 Dec;105 Suppl 2:S135-S146

Centre Hospitalo-Universitaire Régional de Besançon, service d'hématologie, UMR1098 INSERM/UBFC/EFS, 25020 Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0007-4551(19)30044-XDOI Listing
December 2018

Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.

Hum Gene Ther 2018 10;29(10):1202-1212

1 Université Bourgogne Franche-Comté , INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000 Besançon, France; Department of Medical Oncology, F-25000 Besançon, France .

View Article

Download full-text PDF

Source
https://www.liebertpub.com/doi/10.1089/hum.2018.091
Publisher Site
http://dx.doi.org/10.1089/hum.2018.091DOI Listing
October 2018

Personalized identification of tumor-associated immunogenic neoepitopes in hepatocellular carcinoma in complete remission after sorafenib treatment.

Oncotarget 2018 Oct 23;9(83):35394-35407. Epub 2018 Oct 23.

University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Besançon F-25000, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26247DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226040PMC
October 2018

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.

Lancet Oncol 2018 08 2;19(8):1094-1106. Epub 2018 Jul 2.

Department of Oncology, University Hospital of Besancon, Centre Hospitalier Universitaire de Besançon, Besançon, France; Department of Oncology and Radiotherapy, Hôpital Nord Franche Comté, Montbéliard, France; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR) Oncology Multidisciplinary Group, Paris, France; Fédération Francophone de Cancérologie Digestive (FFCD), Dijon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30321-8DOI Listing
August 2018

SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.

Oncoimmunology 2018 17;7(4):e1412030. Epub 2018 Jan 17.

University of Bourgogne Franche-Comté (UBFC), INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1412030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889287PMC
January 2018

A systematic review of economic evaluation in pancreatic ductal adenocarcinoma.

Eur J Cancer 2017 11 9;86:207-216. Epub 2017 Oct 9.

Department of Pharmacy, University Hospital of Besançon, Besançon, France; INSERM UMR 1098, University of Bourgogne - Franche-Comté, Besançon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.08.035DOI Listing
November 2017

Overall Survival Prediction and Usefulness of Second-Line Chemotherapy in Advanced Pancreatic Adenocarcinoma.

J Natl Cancer Inst 2017 10;109(10)

Department of Gastroenterology, Methodological and Quality of Life in Oncology Unit, EA 3181, Department of Digestive Surgery and Liver Transplantation, and Department of Medical Oncology, Besançon University Hospital, Besançon, France; Department of Medical Oncology, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Paris Est Créteil University (UPEC), Créteil, France; Department of Medical Oncology, Institute Mutualiste Montsouris, Paris, France; Department of Hepato-Gastroenterology, Reims University Hospital, Reims, France; INSERM, Unit 1098, and Clinical Investigation Center 1431, University of Bourgogne-Franche-Comté, Besançon, France; Department of Gastroenterology, Vesoul Hospital, Vesoul, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx037DOI Listing
October 2017

A simple and fast LC-MS/MS method with a very high sensitivity for the measurement of raltitrexed in human plasma.

J Chromatogr B Analyt Technol Biomed Life Sci 2017 Aug 13;1060:240-246. Epub 2017 Jun 13.

INSERM, Unit 1098, University of Bourgogne Franche-Comté, F-25020 Besançon, France; CHU Besançon, Department of Pharmacology and Toxicology, F-25030 Besançon Cedex, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2017.06.021DOI Listing
August 2017

GABARAPL1 tumor suppressive function is independent of its conjugation to autophagosomes in MCF-7 breast cancer cells.

Oncotarget 2017 Aug 27;8(34):55998-56020. Epub 2017 Jul 27.

Unité Mixte de Recherche, Interactions Hôte-Greffon-Tumeur, Ingénierie Cellulaire et Génique, Université Bourgogne Franche-Comté, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19639DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593540PMC
August 2017

Dynamic evaluation of circulating tumour cells in patients with advanced gastric and oesogastric junction adenocarcinoma: Prognostic value and early assessment of therapeutic effects.

Eur J Cancer 2017 07 26;79:15-22. Epub 2017 Apr 26.

INSERM U970 - PARCC (Paris Cardiovascular Research Center), Paris Descartes University, Sorbonne Paris Cité, Paris, France; Hôpital Européen Georges-Pompidou, APHP, Department of GI Oncology, Paris Descartes University, Sorbonne Paris Cité, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.03.036DOI Listing
July 2017

In reply.

Semin Oncol 2017 04 4;44(2):161. Epub 2017 Aug 4.

Oncopharmacologie, ICO Paul Papin, Angers, France; Service d'Oncologie Médicale, ICO Paul Papin Angers, France; Service de Gastro-Entérologie, Centre Hospitalier Départemental Les Oudairies, La Roche sur Yon, France; Service d'Oncologie Médicale, CHU Jean Minjoz, Besançon, France; Service d'Oncologie et de Radiothérapie, Institut de Cancérologie et d'Hématologie, Brest, France; Service d'Oncologie Médicale, Centre François Baclesse, Caen, France; Service d'Hépatologie et de Gastroentérologie, Centre Hospitalier, Cholet, France; Service d'Oncologie Médicale, ICO René Gauducheau, Saint Herblain, France; Service d'Hépato-Gastro-Entérologie, Centre Hospitalier Universitaire, Caen, France; Service d'Hépato-Gastro-Entérologie, Centre A. Lacassagne, Nice, France; Service d'Oncologie Médicale, Hôpital Henri Mondor, Creteil, France; Service d'Oncologie Médicale, Centre Hospitalier, Saumur, France; Service d'Onco-Hématologie, Centre Hospitalier, LeMans, France; Service d'Oncologie Médicale, Clinique Gentilly, Nancy, France; Service d'Hépato-Gastro-Entérologie, Proctologie et Oncologie Digestive 5B, Centre Hospitalier, Laval, France; Unité d'Hépato-Gastro-Entérologie,Centre Hospitalier Sartheet Loir, LaFleche, France; Service d'Hépato-Gastro-Entérologie, CHU Hôpital Trousseau, Tours, France; Centre Evaluation Clinique, ICO Paul Papin, Angers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2017.08.002DOI Listing
April 2017

DNA damage response defect in Williams-Beuren syndrome.

Int J Mol Med 2017 Mar 17;39(3):622-628. Epub 2017 Jan 17.

Inserm UMR1098/EFS‑BFC/University of Franche‑Comte, LabEx LipSTIC, F-25000 Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijmm.2017.2861DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5360356PMC
March 2017

[Immuno-oncology and precision medicine: The clinician point of view].

Authors:
Christophe Borg

Ann Pathol 2017 Feb 31;37(1):5-6. Epub 2017 Jan 31.

Oncologie médicale, hôpital Jean-Minjoz, CHU de Besançon, 1, boulevard Fleming, 25020 Besançon, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2016.12.003DOI Listing
February 2017

Fungal peptides from pneumonitis hypersensitivity etiologic agents are able to induce specific cellular immune response.

J Immunol Methods 2017 01 20;440:67-73. Epub 2016 Nov 20.

Chrono-Environnement CNRS 6249 Research Team, Franche-Comté University, Besançon, France; Parasitology-Mycology Department, Besançon University Hospital, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2016.11.009DOI Listing
January 2017

Complete Response to Aflibercept-FOLFIRI in One Patient With Colorectal Cancer Refractory to Bevacizumab-FOLFOX: A Possible Autocrine Vascular Endothelial Growth Factor Receptor 2-Related Mechanism.

Clin Colorectal Cancer 2016 12 9;15(4):e229-e234. Epub 2016 Aug 9.

Department of Medical Oncology, University Hospital of Besançon, Besançon, France; Clinical Investigational Center, CIC-1431, University Hospital of Besançon, Besançon, France; INSERM, Unit 1098, University of Bourgogne Franche-Comté, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clcc.2016.07.015DOI Listing
December 2016

Heparan Sulfate Proteoglycans Promote Telomerase Internalization and MHC Class II Presentation on Dendritic Cells.

J Immunol 2016 09 1;197(5):1597-608. Epub 2016 Aug 1.

INSERM, UMR 1098, 25000 Besançon, France; University of Bourgogne Franche-Comté, 25000 Besançon, France; Department of Medical Oncology, University Hospital of Besançon, 25030 Besançon, France; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1502633DOI Listing
September 2016

Tumor control by human cytomegalovirus in a murine model of hepatocellular carcinoma.

Mol Ther Oncolytics 2016 27;3:16012. Epub 2016 Apr 27.

Department of Virology, Pathogens & Inflammation Laboratory, University of Franche-Comté and COMUE Bourgogne Franche-Comté University, UPRES EA4266, SFR FED 4234, CHRU Besançon , Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mto.2016.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5008266PMC
September 2016

Nanovectorization of DNA Through Cells Using Protamine Complexation.

J Membr Biol 2016 08 24;249(4):493-501. Epub 2016 Mar 24.

Nanomedicine, Imagery and Therapeutics Laboratory, EA - 4662, UFR Sciences et Techniques, CHU-UFR SMP, Université de Bourgogne Franche Comté, 19 Rue Ambroise Paré, 25030, Besancon Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00232-016-9890-5DOI Listing
August 2016

Selective Inhibition of STAT3 with Respect to STAT1: Insights from Molecular Dynamics and Ensemble Docking Simulations.

J Chem Inf Model 2016 08 9;56(8):1588-96. Epub 2016 Aug 9.

Inserm UMR 1098, EFS Bourgogne Franche Comté, Université Bourgogne Franche-Comté , IFR133, 8 rue du Dr Girod, 25020 Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jcim.6b00198DOI Listing
August 2016

Rapalogs Efficacy Relies on the Modulation of Antitumor T-cell Immunity.

Cancer Res 2016 07 17;76(14):4100-12. Epub 2016 May 17.

INSERM UMR1098, TIMC LabEx LipSTIC, Besançon, France. University of Bourgogne Franche-Comté, UMR1098, Besançon, France. Department of Medical Oncology, University Hospital of Besançon, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-2452DOI Listing
July 2016

IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner.

J Immunol 2016 07 27;197(1):85-96. Epub 2016 May 27.

INSERM Unit 1098, University of Franche-Comté, 25000 Besançon, France; Clinical Investigation Center for Biotherapies, 25000 Besançon, France; Etablissement Français du Sang, 25000 Besançon, France; Department of Medical Oncology, University Hospital of Besançon, 25000 Besançon, France; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1501147DOI Listing
July 2016

Efficacy, Safety and Cost of Regorafenib in Patients with Metastatic Colorectal Cancer in French Clinical Practice.

Clin Med Insights Oncol 2016 4;10:59-66. Epub 2016 Jul 4.

INSERM, UMR 1098, Besançon, France.; University of Bourgogne-Franche-Comté, UMR 1098, SFR IBCT, Besançon, France.; Pharmacy Department, Besançon University Hospital, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMO.S38335DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933532PMC
July 2016

Immunophenotyping of Stage III Melanoma Reveals Parameters Associated with Patient Prognosis.

J Invest Dermatol 2016 05 29;136(5):994-1001. Epub 2016 Jan 29.

INSERM U1015, Gustave Roussy Cancer Center, Villejuif, France; University Paris Saclay, Kremlin Bicêtre, France; Gustave Roussy Cancer Center, Villejuif, France; CIC Biothérapie IGR Curie CIC1428, Gustave Roussy Cancer Center, Villejuif, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jid.2015.12.042DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156792PMC
May 2016

Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4(+) Th1 responses against telomerase in cancer patients.

Oncoimmunology 2016 May 18;5(5):e1137416. Epub 2016 Feb 18.

INSERM, UMR1098, LabEx LipSTIC, Besançon, France; Univ. Bourgogne Franche-Comté, UMR1098, Besançon, France; Department of Medical Oncology, University Hospital of Besançon, Besançon cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1137416DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910811PMC
May 2016

Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer.

Oncoimmunology 2017 13;6(1):e1163456. Epub 2016 May 13.

Gustave Roussy Cancer Campus (GRCC), Villejuif, France; INSERM, GRCC, Villejuif, France; Center of Clinical Investigations in Biotherapies of Cancer (CICBT), GRCC, Villejuif, France; University of Paris Sud XI, Kremlin Bicêtre, France; Department of Immuno-Oncology, GRCC, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1163456DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5283624PMC
May 2016

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.

Exp Hematol Oncol 2015 14;5:10. Epub 2016 Apr 14.

INSERM UMR1098, Établissement Français du Sang Bourgogne Franche Comté, Université de Franche-Comté, SFR FED4234, 25020 Besançon, France ; Laboratoire de Thérapeutique Immuno-Moléculaire et cellulaire des cancers, INSERM UMR1098, Etablissement Français du Sang-Bourgogne/Franche-Comté, 8, rue du Docteur Jean-François-Xavier Girod, 25020 Besançon Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40164-016-0038-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831155PMC
April 2016

New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.

Exp Hematol Oncol 2015 1;5. Epub 2016 Mar 1.

INSERM UMR1098, Établissement Français du Sang Bourgogne Franche Comté, Université de Franche-Comté, SFR FED4234, 25020 Besançon, France ; Laboratoire de Thérapeutique Immuno-Moléculaire et cellulaire des cancers, INSERM UMR1098, Etablissement Français du Sang-Bourgogne/Franche-Comté, 8, rue du Docteur Jean-François-Xavier Girod, 25020 Besançon Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40164-016-0036-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4774009PMC
March 2016

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1.

Science 2015 Nov 29;350(6263):972-8. Epub 2015 Oct 29.

Gustave Roussy Cancer Campus, Villejuif, France. INSERM, U1138, Paris, France. Équipe 11 Labellisée par la Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France. Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Université Pierre et Marie Curie, Paris, France. Metabolomics and Cell Biology Platforms, Gustave Roussy Cancer Campus, Villejuif, France. Pôle de Biologie, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. Karolinska Institute, Department of Women's and Children's Health, Karolinska University Hospital, 17176 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aad0779DOI Listing
November 2015

Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors.

Eur J Med Chem 2015 Oct 1;103:163-74. Epub 2015 Sep 1.

Nanomedicine Lab, EA - 4662, UFR SMP 19 rue Ambroise Paré Université de Franche Comté, 25030 Besançon Cedex, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmech.2015.08.054DOI Listing
October 2015

[Anti-angiogenic treatments in metastatic colorectal cancer: Does a continuous angiogenic blockade make sense?].

Bull Cancer 2015 Sep 29;102(9):758-71. Epub 2015 Jul 29.

Institut de cancérologie de l'Ouest, Nantes-Angers, 44805 Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2015.05.002DOI Listing
September 2015

Gemcitabine-Induced Pulmonary Toxicity: A Case Report of Pulmonary Veno-Occlusive Disease.

Clin Med Insights Oncol 2015 1;9:75-9. Epub 2015 Sep 1.

Department of Medical Oncology, University Hospital of Besançon, Besançon, France. ; INSERM, Unit 1098, University of Franche-Comté, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4137/CMO.S26537DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559186PMC
September 2015

CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes.

Int J Cancer 2015 Jul 12;137(1):116-26. Epub 2014 Dec 12.

INSERM UMR1098, F25020 Besançon cedex, France; Université de Franche-Comté, F25020 Besançon cedex, France; EFS Bourgogne Franche-Comté, F25020 Besançon cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29366DOI Listing
July 2015

Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine.

Vaccines (Basel) 2015 Jun 30;3(3):490-502. Epub 2015 Jun 30.

INSERM UMR1098, Besançon cedex F25020, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/vaccines3030490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586463PMC
June 2015

The impact of taxane-based preoperative chemotherapy in gastroesophageal signet ring cell adenocarcinomas.

J Hematol Oncol 2015 May 15;8:52. Epub 2015 May 15.

Department of Medical Oncology, University Hospital of Besancon, 3 Boulevard Alexander Fleming, Besancon, F-25030, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-015-0148-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4440289PMC
May 2015

Prognostic value of angiopoietin-2 for death risk stratification in patients with metastatic colorectal carcinoma.

Cancer Epidemiol Biomarkers Prev 2015 Mar 12;24(3):603-12. Epub 2015 Jan 12.

Department of Medical Oncology, University Hospital, Besançon, France. INSERM, Unit 1098, University of Franche-Comté, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-1059DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805754PMC
March 2015

QSOX1 inhibits autophagic flux in breast cancer cells.

PLoS One 2014 24;9(1):e86641. Epub 2014 Jan 24.

Université de Franche-Comté, Estrogènes, Expression Génique et Pathologies du Système Nerveux Central, U.F.R. Sciences et Techniques, Besançon, Doubs, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086641PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901705PMC
February 2015

Investigating the impact of Echinococcus multilocularis vesicular fluid on human cells from healthy blood donors.

J Immunol Methods 2015 Feb 13;417:52-59. Epub 2014 Dec 13.

Parasitology-Mycology Department, Besançon University Hospital, F-25000 Besançon, France; Franche-Comté University, F-25000 Besançon, France; CNRS 6249 /UMR "Chrono-environnement", F-25000 Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2014.12.006DOI Listing
February 2015

Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review.

Cancer Med 2014 Dec 11;3(6):1502-11. Epub 2014 Aug 11.

Department of Medical Oncology, University Hospital of Besançon, Besançon, France; Methodology and Quality of Life in Oncology Unit, University Hospital of Besançon, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.299DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298376PMC
December 2014

Constitutional and somatic deletions of the Williams-Beuren syndrome critical region in non-Hodgkin lymphoma.

J Hematol Oncol 2014 Nov 7;7:82. Epub 2014 Nov 7.

Laboratory of Cellular and Molecular Biology, University Hospital of Besançon, 1 Bd Fleming, Batiment Diaclone, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-014-0082-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228180PMC
November 2014

QSOX1 inhibits autophagic flux in breast cancer cells.

PLoS One 2014 24;9(1):e86641. Epub 2014 Jan 24.

Université de Franche-Comté, Estrogènes, Expression Génique et Pathologies du Système Nerveux Central, U.F.R. Sciences et Techniques, Besançon, Doubs, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086641PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901705PMC
February 2015

Immunomodulatory effects of everolimus in a long responsive patient with metastatic renal cell carcinoma.

J Immunother 2014 Jan;37(1):51-4

*Oncologie, Besançon Cedex §CIC-BT506, CHRU †INSERM, UMR1098 ‡UMR1098, Université de Franche-Comté ∥EFS Bourgogne Franche-Comté ¶Laboratoire de Pharmacologie Clinique et Toxicologie, Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000006DOI Listing
January 2014

Metronomic cyclophosphamide: an alternative treatment for hepatic epithelioid hemangioendothelioma.

J Hepatol 2013 Jun 8;58(6):1254-7. Epub 2013 Feb 8.

Department of Digestive Surgery and Liver Transplantation, University Hospital of Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2013.01.043DOI Listing
June 2013

Targeting antitumor CD4 helper T cells with universal tumor-reactive helper peptides derived from telomerase for cancer vaccine.

Hum Vaccin Immunother 2013 May 28;9(5):1073-7. Epub 2013 Jan 28.

INSERM; Unité Mixte de Recherche 1098; Besançon, France; Etablissement Français du Sang de Bourgogne Franche-Comté; UMR1098; Besançon cedex, France; Université de Franche-Comté; UMR1098 ; SFR IBCT; Besançon, France; CHRU de Besançon ; Service d'Oncologie; Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/hv.23587DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899142PMC
May 2013

Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?

Oncoimmunology 2012 Dec;1(9):1617-1619

INSERM U1098; Unité Mixte de Recherche; Besançon, France ; Etablissement Français du Sang de Bourgogne Franche-Comté; Besançon, France ; Université de Franche-Comté; Besançon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.21513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525622PMC
December 2012